Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) Files An 8-K Results of Operations and Financial Condition

Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item2.02

Results of Operations and Financial
Condition.

On March 31, 2017, the Company issued a press release announcing
the results of the Companys operations for the fourth quarter and
fiscal year ended December 31, 2016. The full text of the press
release is furnished as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference in this Item 2.02.

The information in this Form 8-K and Exhibit 99.1 is being
furnished to Item 2.02 of Form 8-K and shall not be deemed to be
filed for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the Exchange Act), or otherwise subject to
the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing made by the Company under
the Securities Act of 1933, as amended, or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.

Item9.01 Financial Statements and Exhibits.

Exhibit

Number

Description
99.1 Press release, dated March 31, 2017, of Yew Bio-Group, Inc.

(s)


About Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB)

Yew Bio-Pharm Group, Inc. is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The Company operates through five segments: traditional Chinese medicine (TCM) raw materials, which is engaged in the production and sale of raw materials used for medicinal application in the pharmaceutical industry; yew trees, which is engaged in the cultivation and sale of yew seedlings, yew trees and potted yew trees; handicrafts, which is engaged in the manufacture and sale of furniture and handicrafts made of yew timber; wood ear mushroom, which includes the sale of wood ear mushroom, and others, which includes the sale of yew candles and pine needle extracts. It is engaged in processing and selling yew raw materials used in the manufacture of TCM; growing and selling yew tree seedlings and mature trees, including potted miniature yew trees; manufacturing and selling furniture and handicrafts made of yew tree timber, and selling agricultural products.

Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) Recent Trading Information

Yew Bio-Pharm Group, Inc. (OTCMKTS:YEWB) closed its last trading session 00.000 at 0.280 with 5,000 shares trading hands.

An ad to help with our costs